RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Andrew Taylor to Antirheumatic Agents

Back to Details
This is a "connection" page, showing publications Andrew Taylor has written about Antirheumatic Agents.
Andrew Taylor
Connection Strength
0.086
Antirheumatic Agents
  1. Bilsborough W, Keen H, Taylor A, O'Driscoll GJ, Arnolda L, Green DJ. Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis. Rheumatol Int. 2006 Oct; 26(12):1125-31.
    View in: PubMed
    Score: 0.069
  2. Vanags D, Williams B, Johnson B, Hall S, Nash P, Taylor A, Weiss J, Feeney D. Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial. Lancet. 2006 Sep 02; 368(9538):855-63.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support